ABCC3
MOLECULAR TARGETATP binding cassette subfamily C member 3
ABCC3 (ATP binding cassette subfamily C member 3) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ABCC3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Abacavir | 0.69 | 1 |
| 2 | Methotrexate | 0.69 | 1 |
| 3 | cefaclor | 0.69 | 1 |
| 4 | Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as | 0.69 | 1 |
| 5 | Cefmetazole | 0.69 | 1 |
| 6 | Cefoperazone Semisynthetic broad-spectrum cephalosporin with | 0.69 | 1 |
| 7 | Cefoxitin | 0.69 | 1 |
| 8 | Ceftriaxone | 0.69 | 1 |
| 9 | cefuroxime | 0.69 | 1 |
| 10 | Cephradine | 0.69 | 1 |
| 11 | Delavirdine | 0.69 | 1 |
| 12 | Emtricitabine | 0.69 | 1 |
| 13 | Lamivudine | 0.69 | 1 |
| 14 | Olmesartan Medoxomil | 0.69 | 1 |
| 15 | Rimonabant | 0.69 | 1 |
About ABCC3 as a Drug Target
ABCC3 (ATP binding cassette subfamily C member 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented ABCC3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ABCC3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.